Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
The Lancet. Oncology|October 4, 2005
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trialJens Overgaard, Jesper Grau Eriksen, Marianne Nordsmark, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2007
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patientsMarianne Nordsmark, Jesper Grau Eriksen, Val Gebski, et al.
Acta Oncologica (Stockholm, Sweden)|January 14, 2016
Trends in cancer of the head and neck in the elderly in Denmark, 1980-2012Jørgen Johansen, Jesper Grau Eriksen,
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 20, 2016
Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer RadiotherapyJesper Grau Eriksen, Pernille Lassen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2007
Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 studyJesper Grau Eriksen, Jens Overgaard,
Acta Oncologica (Stockholm, Sweden)|October 5, 2012
The psychosocial work environment among physicians employed at Danish oncology departments in 2009. A nationwide cross-sectional studyChristian Nicolaj Andreassen, Jesper Grau Eriksen
Acta Oncologica (Stockholm, Sweden)|April 26, 2005
The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinomaJesper Grau Eriksen, Torben Steiniche, Jens Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2013
Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trialsPernille Lassen, Jens Overgaard, Jesper Grau Eriksen
Acta Oncologica (Stockholm, Sweden)|August 19, 2021
The effects of PD-1/PD-L1 checkpoint inhibitors on recurrent/metastatic head and neck squamous cell carcinoma: a critical review of the literature and meta-analysisEmily Clarke, Jesper Grau Eriksen, Sarah Barrett
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 30, 2010
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecanBenedikte Hasselbalch, Jesper Grau Eriksen, Helle Broholm, et al.
Pageof 22